Latest Transformation News

MyState Limited’s merger with Auswide Bank has driven a 17% rise in underlying net profit to $41.3 million for FY25, alongside a strengthened capital position and a fully franked 11 cent dividend.

Arafura Rare Earths has received conditional approval for a US$100 million equity investment from Export Finance Australia, reinforcing the strategic importance of its Nolans Project in Australia’s critical minerals landscape.

Solis Minerals has raised $5.9 million to fund the acquisition and exploration of its promising Cucho copper project, alongside ongoing and upcoming drilling programs at Ilo Este and Cinto in Peru.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

Invion Limited has partnered with Protect Animal Health to explore Photosoft™, a novel photodynamic therapy, as a treatment for cancer in companion animals, targeting a booming pet cancer market.

VHM Limited has obtained conditional financial backing of up to A$379 million from Export Finance Australia and the US Export-Import Bank to advance its Goschen Rare Earths and Mineral Sands Project in Victoria.

Veris Limited has reversed its FY24 loss to post a $2.0 million profit before tax in FY25, driven by digital growth and strategic acquisitions. The company’s focus on higher-margin consulting and advisory services underpins a positive outlook for FY26.

Findi Limited has arranged a new A$30 million debt facility and agreed to acquire Sphere, enhancing its digital payments ecosystem ahead of a planned FY27 Indian IPO. Despite short-term challenges, the company projects strong revenue growth and operational momentum in FY26.

Latrobe Magnesium Limited has received a non-binding Letter of Interest from the U.S. Export Import Bank to finance up to A$200 million for its Stage 2 Commercial Magnesium Plant, aiming to strengthen critical mineral supply chains for the U.S.

Iondrive Limited has inked a binding term sheet with LAT66 Limited to apply its innovative Deep Eutectic Solvent technology to cobalt-rich concentrates from Finland’s Kuusamo projects, marking a strategic step beyond battery recycling into primary mineral processing.

Neurizon Therapeutics has been granted a key Australian patent for its lead drug candidate NUZ-001, extending protection for treatments targeting ALS, Alzheimer's, and other neurodegenerative diseases through 2041. This milestone complements earlier US patent grants and sets the stage for upcoming clinical trials.

Galan Lithium has secured new exploration licences adjacent to the world-class Greenbushes lithium mine, setting the stage for a targeted Australian exploration program alongside its flagship Argentine projects.